ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

AZASAN
Arthritis/rheumatic disorders
Organ rejection prophylaxis
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

AZASAN Rx

Generic Name and Formulations:
Azathioprine 75mg, 100mg; scored tabs.

Company:
Valeant Pharmaceuticals, Inc

Therapeutic Use:

Indications for AZASAN:

To reduce signs/symptoms of active rheumatoid arthritis; may be used with aspirin, NSAIDs, and/or low dose corticosteroids.

Adult:

Initially: 1mg/kg (50mg–100mg) daily in 1–2 divided doses; after 6–8 wks, if needed, may increase by 0.5mg/kg daily increments every 4-weeks. Max: 2.5mg/kg per day. Maintenance: use lowest effective dose.

Children:

Not recommended.

Contraindications:

Pregnancy (Cat.D). Prior treatment with alkylating agents (eg, cyclophosphamide, chlorambucil, melphalan, or others) may increase risk of neoplasia.

Warnings/Precautions:

Be fully familiar with product's toxicity before use. Risk of myelotoxicity with low or absent thiopurine S-methyl transferase (TPMT) activity. Monitor blood. Impaired renal function. Discontinue if ineffective after 12 weeks. Nursing mothers: not recommended.

Interactions:

Reduce dose to ⅓ or ¼ with allopurinol. TPMT enzyme inhibition with aminosalicylates (eg, sulphasalazine, mesalazine, olsalazine). Leukopenia with co-trimoxazole. Anemia, leukopenia with ACE Inhibitors. May antagonize warfarin.

Pharmacological Class:

Immunosuppressant.

Adverse Reactions:

Severe leukopenia and/or thrombocytopenia, macrocytic anemia, pancytopenia, severe bone marrow suppression, GI disturbances, secondary infections, mutagenic and carcinogenic potential, hepatotoxicity, rash.

Generic Availability:

YES

How Supplied:

Tabs—100

Indications for AZASAN:

Adjunct for the prevention of rejection in renal homotransplantation.

Adult:

Start at time of transplant or 1–3 days prior; usually with IV formulation. Initially: 3–5 mg/kg daily. Maintenance: 1–3mg/kg daily.

Children:

Not recommended.

Contraindications:

Pregnancy (Cat.D).

Warnings/Precautions:

Be fully familiar with product's toxicity before use; consider discontinuing if severe toxicity occurs. Risk of myelotoxicity with low or absent thiopurine S-methyl transferase (TPMT) activity. Monitor blood. Impaired renal function. Nursing mothers: not recommended.

Interactions:

Reduce dose to ⅓ or ¼ with allopurinol. TPMT enzyme inhibition with aminosalicylates (eg, sulphasalazine, mesalazine, olsalazine). Leukopenia with co-trimoxazole. Anemia, leukopenia with ACE Inhibitors. May antagonize warfarin.

Pharmacological Class:

Immunosuppressant.

Adverse Reactions:

Severe leukopenia and/or thrombocytopenia, macrocytic anemia, pancytopenia, severe bone marrow suppression, GI disturbances, secondary infections, mutagenic and carcinogenic potential, hepatotoxicity, rash.

Generic Availability:

YES

How Supplied:

Tabs—100

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs